Medical Polymer

Medical Polymer Market by Type (Biological, Hybrid, Synthetic), Material (Polycarbonates (PC), Polyethylene (PE), Polyethylene Terephthalate Glycol (PETG)), Product, Application - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the medical polymer market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[180 Pages Report] The Medical Polymer Market size was estimated at USD 23.92 billion in 2023 and expected to reach USD 25.82 billion in 2024, at a CAGR 8.13% to reach USD 41.36 billion by 2030.

Medical Polymer Market
To learn more about this report, request a free PDF copy

Medical or clinical-grade polymers are utilized as additives and fillers in clinical plastics and for other clinical devices and packaging. Medical polymers are biocompatible in nature and remain stagnant or are smoothly processed by the human body. Healthcare industry are adopting medical polymers widely, with significant efforts to commercialize new medical polymers to meet the specification of high-end applications. The demand for polymers in the healthcare market is growing significantly due to a substantial increase in the need for medical implants due to the increased need to monitor body functions and support organs and tissues. However, unsteady expenses of raw materials and the implementation of stringent regulations impede the adoption of medical polymers. In addition, several manufacturers display therapeutic polymers with varying molecular weights, crosslinking and crystallization levels, copolymers and blends, and bioactive surface fictionalization. Furthermore, the growing attraction to novel and inventive healthcare devices is increasing the need for clinical polymers globally to aid in device innovation and supportability.

Medical Polymer Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Regional Insights

In the Americas region, the rising demand for medical polymers in pharmaceutical packaging applications and the rapid growth of pharmaceutical industries in Mexico and Canada is expected to increase the need for medical polymers. The presence of key government initiatives such as the Affordable Care Act (ACA) and Medicaid has enabled a large percentage of the population to gain access to healthcare facilities and services in the United States. This has further boosted the need for advanced drugs, medical devices, and healthcare services, thereby driving the need for medical polymers in the country, primarily in applications such as medical components, packaging, and wound care. Increasing government investments in the healthcare sector and the growing home healthcare market are anticipated to drive the need for medical devices, which is expected to positively influence medical polymers' growth. In Europe, government organizations are pushing R&D investment in the pharmaceutical business to build technically complex equipment that aids in the elimination of dangerous ailments in the region. The increasing need to develop novel medical gadgets benefits the medical polymers market growth over the forecast period across Europe. In the Middle East and Africa, the stringent requirements for effective pharmaceutical and medical device packaging have led to the development of various innovative medical polymer films.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Medical Polymer Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Polymer Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • DuPont Liveo Healthcare Solutions introduces new developments in low-cyclic silicone elastomer blends and silicone resin blends for topical applications

    DuPont Liveo Healthcare Solutions has recently introduced new advancements in low cyclic silicone elastomer blends and silicone resin blends, specifically for topical medical applications. These developments have the potential to revolutionize the medical polymer market, providing medical professionals with innovative solutions for patient care. With a focus on delivering high-quality, durable products, DuPont Liveo Healthcare Solutions is committed to meeting the needs of the medical industry. As the demand for medical-grade polymers continues to grow, these new developments from DuPont Liveo Healthcare Solutions offer promising solutions that could have a significant impact on the future of the medical industry. [Published On: 2023-04-13]

  • Stratasys Completes Acquisition of Covestro’s Additive Manufacturing Materials Business

    Stratasys, a global leader in additive manufacturing technology, has recently completed the acquisition of the additive manufacturing materials business of Covestro, a leading manufacturer of high-performance polymers. With this acquisition, Stratasys aims to expand its portfolio of materials, specifically in the medical industry. The medical polymer market is rapidly growing, and the demand for innovative and high-quality materials is at an all-time high. By investing in this area, Stratasys solidifies its commitment to providing the best solutions for the medical industry and reinforces its position as a market leader. This acquisition reinforces Stratasys' vision of transforming traditional manufacturing through the power of additive manufacturing. [Published On: 2023-04-05]

  • Formerra expands its global footprint and leading healthcare offering with the acquisition of total polymer solutions

    Formerra, the leading medical polymer manufacturer, recently announced a significant expansion of its global footprint. The company has always been committed to creating high-quality medical devices and equipment through the development of innovative materials. With this expansion, Formerra is poised to extend its reach in key markets and further solidify its position as a leader in the industry. The new locations are strategically positioned to increase efficiency in supply chain management and improve overall production. Formerra's dedication to scientific research and development will continue to make a difference in the lives of patients around the world, as the company shapes the future of the medical polymer industry. [Published On: 2023-04-04]

Key Company Profiles

The report delves into recent significant developments in the Medical Polymer Market, highlighting leading vendors and their innovative profiles. These include Arihant Polymers, Arkema, Avient Corporation, BASF SE, Celanese Corporation, Covestro AG, Dow Inc., Eastman Chemical Corporation, ELIX Polymers, Evonik Industries AG, Exxon Mobil Corporation, Huizhou Foryou Medical Devices Co., Ltd., IMCD Group, Innovative Polymer Compounds Ltd., Kent Elastomer Products, Koninklijke DSM N.V., KRATON CORPORATION, Lubrizol Corporation, Makevale Limited, NatureWorks LLC, Poly-Med Inc., SABIC, Seqens, Solvay S.A., Topas Advanced Polymers GmbH, Trelleborg Group, Trinseo PLC, Victrex PLC, and Zeus Company Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Polymer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Biological
    • Hybrid
    • Synthetic
  • Material
    • Polycarbonates (PC)
    • Polyethylene (PE)
    • Polyethylene Terephthalate Glycol (PETG)
    • Polymethyl Methacrylate (PMMA)
    • Polypropylene (PP)
    • Polystyrene (PS)
    • Polyvinyl Chloride (PVC)
  • Product
    • Biodegradable Medical Plastics
    • Medical Elastomers
    • Medical Fibers & Resins
  • Application
    • Biopharmaceutical Processing
    • Medical Devices & Equipment
    • Medical Packaging

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Medical Polymer Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Polymer Market?
  3. What are the technology trends and regulatory frameworks in the Medical Polymer Market?
  4. What is the market share of the leading vendors in the Medical Polymer Market?
  5. Which modes and strategic moves are suitable for entering the Medical Polymer Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Medical Polymer Market, by Type
  7. Medical Polymer Market, by Material
  8. Medical Polymer Market, by Product
  9. Medical Polymer Market, by Application
  10. Americas Medical Polymer Market
  11. Asia-Pacific Medical Polymer Market
  12. Europe, Middle East & Africa Medical Polymer Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 384]
  17. List of Companies Mentioned [Total: 29]
The Benefits of Medical Polymers in Lightweight Surgical and Operative Devices
June 22, 2023
BLOG
The Benefits of Medical Polymers in Lightweight Surgical and Operative Devices
In the medical industry, there is a constant push to innovate and make medical procedures less invasive, more efficient and improve patient outcomes. Lightweight surgical and operative devices have become an important aspect of many medical procedures. These devices are easier to handle and manipulate and have decreased operating times. An essential component of these devices is the medical polymer construction materials. To further understand the benefits of these polymers in lightweight surgical and operative devices, let us explore the topic in more detail.

Greater Flexibility:

One of the most significant advantages of medical polymers in lightweight surgical and operative devices is their flexibility. These devices often require materials that are pliable enough to flex and twist while maintaining their integrity. Medical polymers can meet this challenge as they possess unique properties such as high flexibility, durability, and elasticity, which are critical for medical devices that need to move, bend, or stretch.

Less Risk of Infection:

The unique benefits of medical polymers over traditional materials such as metals like steel and aluminum are their ability to combat bacterial infections. Polymers either have an inherent antimicrobial property or can be coated with an antimicrobial layer that actively reduces the risk of bacterial infection spreading. This coating differentiates medical polymers from metals that may harbor and transmit bacterial infections.

Cost-effective:

Medical polymer production is a much more cost-effective process than most other traditional materials. Unlike metal, they do not have to undergo complex and costly fabrication processes. Also, medical polymers are relatively easy to manufacture, durable, and have a lower weight, which results in less equipment wear and breakdown. The low maintenance requirement and cost-effective nature of medical polymers make them a desirable option for lightweight surgical and operative devices.

Improved Patient Recovery Time:

Finally, the use of medical polymers in lightweight surgical and operative devices results in shortened procedure time, low risk of infection, and less invasive methods. Since medical polymers make it easier to produce highly flexible and precise devices, surgeons and other medical specialists can perform less invasive procedures that result in quicker patient recovery times. It also reduces the overall time the patient has to spend in the hospital, resulting in less downtime and less stress.

Medical polymers used in lightweight surgical and operative devices provide medical professionals, patients, and manufacturers enormous benefits. The properties of these materials make them flexible yet durable, at the same time providing outstanding resistance to bacterial infections. This makes them superior to traditional metallic materials. Medical polymers offer a more cost-effective, less invasive, and quicker method of providing high-quality care to patients. Therefore, the number of people turning to medical polymers for their medical innovations and breakthroughs is surging drastically.

Frequently Asked Questions
  1. How big is the Medical Polymer Market?
    Ans. The Global Medical Polymer Market size was estimated at USD 23.92 billion in 2023 and expected to reach USD 25.82 billion in 2024.
  2. What is the Medical Polymer Market growth?
    Ans. The Global Medical Polymer Market to grow USD 41.36 billion by 2030, at a CAGR of 8.13%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.